Doctor profile · Federal record
Dr. Amy Avant, APRN-BC
Family Nurse Practitioner (CMS: Nurse Practitioner) · Leawood, KS
- NPI 1568831584
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
11550 Granada St Ste 200
Leawood, KS 662111453
(913) 374-6711 - Mailing address
-
5310 Harvest Hill RD Ste 290
Dallas, TX 752305826
Credentials & registration
- NPI registered
- September 2015 — 11 yrs on file
- Profile last updated
- October 5, 2022
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Kansas #53-76937-012
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568831584. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,284
Distinct HCPCS
10
Medicare allowed
$100,850
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 836 | 184 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 377 | 269 | $71 | |
17000 |
Destruction of precancer skin growth, 1 growth | 307 | 230 | $40 | |
11102 |
Biopsy of related skin growth, first growth | 176 | 153 | $70 | |
17110 |
Destruction of skin growth, 1-14 growths | 152 | 126 | $86 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 104 | 86 | $101 | |
11103 |
Biopsy of related skin growth, each additional growth | 96 | 53 | $39 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 71 | 71 | $88 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 37 | 37 | $132 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 36 | 12 | $1 |
In context: peer comparison
Among 14 peers in Leawood Family Nurse Practitioner, average services per provider: 167. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$3,708
Transactions
138
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Leo Pharma INC. | 7 | $811.91 | |
| Abbvie INC. | 24 | $404.76 | |
| Dermavant Sciences, INC. | 25 | $350.92 | |
| E.R. Squibb & Sons, L.L.C. | 21 | $349.19 | |
| Janssen Biotech, INC. | 7 | $216.84 | |
| Amgen INC. | 11 | $192.43 | |
| Arcutis Biotherapeutics, INC. | 6 | $174.26 | |
| Genzyme Corporation | 3 | $164.40 | |
| Ucb, INC. | 11 | $147.90 | |
| Organogenesis INC. | 1 | $144.55 | |
| Novartis Pharmaceuticals Corporation | 6 | $141.63 | |
| Galderma Laboratories, L.P. | 5 | $137.02 | |
| Incyte Corporation | 6 | $134.53 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $83.94 | |
| Sun Pharmaceutical Industries INC. | 4 | $71.81 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
387
Patients
252
Total drug cost
$10,005
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 82 | 59 | $786 |
| Ketoconazole | Generic | 78 | 40 | $1,653 |
| Clobetasol Propionate | Generic | 55 | 38 | $2,936 |
| Mupirocin | Generic | 44 | 37 | $378 |
| Hydrocortisone | Generic | 40 | 33 | $187 |
| Fluorouracil | Generic | 29 | 25 | $3,142 |
| Doxycycline Hyclate | Generic | 28 | 20 | $637 |
| Finasteride | Generic | 18 | 0 | $162 |
| Fluconazole | Generic | 13 | 0 | $123 |
Frequently asked questions
What is Dr. Amy Avant's medical specialty?
Dr. Amy Avant practices Family Nurse Practitioner in Leawood, KS.
Where does Dr. Amy Avant practice?
Dr. Amy Avant practices at 11550 Granada St Ste 200, Leawood, KS 662111453. Office phone: 9133746711.
What is Dr. Amy Avant's NPI?
Dr. Amy Avant's National Provider Identifier (NPI) is 1568831584, issued by NPPES.
Does Dr. Amy Avant accept Medicare assignment?
Yes. Dr. Amy Avant accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amy Avant commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.